Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Baxter
Harvard Business School
McKesson
Colorcon

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Patent: 9,150,877

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,150,877
Title:Construct and method for expressing transgenes using a Brassica bidirectional constitutive promoter
Abstract: Provided are constructs and methods for expressing multiple genes in plant cells and/or plant tissues using a disclosed bidirectional promoter from Brassica napus or Brassica bidirectional constitutive promoter (BBCP). The constructs provided comprise at least one such bi-directional promoter linked to multiple gene expression cassettes, wherein each of the gene expression cassettes comprises at least one transgene. In some embodiments, the constructs and methods provided allow expression of genes between two and twenty.
Inventor(s): Gupta; Manju (Carmel, IN), Russell; Sean Michael (Carmel, IN), Shen; Liu Yin (Westfield, IN), Chennareddy; Sivarama Reddy (West Lafayette, IN), Rout; Jyoti (Portland, OR), Novak; Stephen (Westfield, IN)
Assignee: Dow AgroSciences LLC (Indianapolis, IN)
Application Number:13/653,602
Patent Claims:see list of patent claims

Details for Patent 9,150,877

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Dow AgroSciences LLC (Indianapolis, IN) 2027-09-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Dow AgroSciences LLC (Indianapolis, IN) 2027-09-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Dow AgroSciences LLC (Indianapolis, IN) 2027-09-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
Colorcon
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.